11/13/2024
10:20 AM | INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/07/2024
9:21 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
1:59 PM | Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
1:59 PM | Freeman Jonathan E (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
2:00 PM | Infarinato Robert M. (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:10 PM | BRADFORD PATRICIA A (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:11 PM | Ferrara Robert L (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/12/2024
3:11 PM | Lockshin Curtis (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:14 PM | Infarinato Robert M. (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:45 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
8:05 AM | Infarinato Robert M. (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/05/2024
7:00 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B3 | |
08/01/2024
11:15 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form EFFECT | |
08/01/2024
7:00 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:30 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/24/2024
3:30 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
3:30 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2024
7:01 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
11:15 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form EFFECT | |
06/21/2024
3:45 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
8:04 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B5 | |
05/17/2024
8:00 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
4:20 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
4:23 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
4:05 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form PRE 14A | |
04/02/2024
6:30 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
3:31 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
3:42 PM | Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
6:00 PM | Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
6:03 PM | Kontulis Caitlin (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
9:30 AM | INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/28/2023
8:13 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B3 | |
12/27/2023
11:15 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form EFFECT | |
12/19/2023
3:52 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/19/2023
12:07 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/08/2023
4:00 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
